Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid Leukemia
Fabio Forghieri, Giovanni Riva, Ivana Lagreca, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9159-9159
Open Access | Times Cited: 12

Showing 12 citing articles:

Multiparametric Flow Cytometry for MRD Monitoring in Hematologic Malignancies: Clinical Applications and New Challenges
Giovanni Riva, Vincenzo Nasillo, Anna Maria Ottomano, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4582-4582
Open Access | Times Cited: 43
Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (NPM1) Mutation
Lynn Chin, Chantelle Ye Gwen Wong, Harinder Gill
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3161-3161
Open Access | Times Cited: 14
Selective HLA Haplotype Loss in Npm1‐Positive Acute Myeloid Leukaemia: A Model of Immunological Escape
Giovanni Rombolà, Roberto Crocchiolo, Michela Falco, et al.
HLA (2025) Vol. 105, Iss. 2
Closed Access
The Immunotherapy of Acute Myeloid Leukemia: A Clinical Point of View
Federico Mosna
Cancers (2024) Vol. 16, Iss. 13, pp. 2359-2359
Open Access | Times Cited: 3
Association between Immunophenotypic Parameters and Molecular Alterations in Acute Myeloid Leukemia
Flávia Melo Cunha de Pinho Pessoa, Caio Bezerra Machado, Igor Valentim Barreto, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1098-1098
Open Access | Times Cited: 9
When inflammatory stressors dramatically change, disease phenotypes may transform between autoimmune hematopoietic failure and myeloid neoplasms
Xi-Chen Zhao, Bo Ju, Nuan-Nuan Xiu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Immunotherapeutic Potential of Mutated NPM1 for the Treatment of AML
Jochen Greiner, Eithar Mohamed, Daniel Fletcher, et al.
(2024)
Open Access | Times Cited: 1
Immunotherapeutic Potential of Mutated NPM1 for the Treatment of Acute Myeloid Leukemia
Jochen Greiner, Eithar Mohamed, Daniel Fletcher, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3443-3443
Open Access | Times Cited: 1
Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies
Ivana Lagreca, Vincenzo Nasillo, Patrizia Barozzi, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 972-972
Open Access | Times Cited: 1
Frameshift Mutations in Leukemia-Associated Genes Correlate With Superior Outcomes in Patients Undergoing Allogeneic Stem Cell Transplant for De Novo Acute Myeloid Leukemia
Emma Cammann, Sindha Madhav, Lloyd Hutchinson, et al.
Journal of Hematology (2024) Vol. 13, Iss. 3, pp. 86-93
Open Access
Molecular Immunology in Hematological Disorders
Akiyoshi Takami
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9584-9584
Open Access | Times Cited: 1
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia
Marica De Cicco, Ivana Lagreca, Sabrina Basso, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2731-2731
Open Access
Page 1

Scroll to top